Decision letter for "Bioequivalence of budesonide/glycopyrrolate/formoterol fumarate with a next-generation propellant versus hydrofluoroalkane-134a in healthy adults: Phase I, randomized, double-blind, single-dose, partial-replicate, 3-way cross-over lung exposure and total systemic exposure studies"

Publons reviews and discussion 2026

View at publisher

DOI: 10.1177/17534666261417149/v3/decision1

Cited by: 0

Fields of Study & Subjects

Inhalation and Respiratory Drug Delivery Asthma and respiratory diseases Pharmaceutical studies and practices